Mariaconcetta Durante Selected Research

Mariaconcetta Durante Research Topics

Disease

5	Fibrosis (Cirrhosis) 11/2023 - 01/2016
4	Neuralgia (Stump Neuralgia) 10/2021 - 01/2017
4	Inflammation (Inflammations) 10/2020 - 01/2016
3	Glaucoma 02/2019 - 01/2016
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2023 - 01/2016
2	Hyperalgesia 10/2021 - 01/2017
2	Body Weight (Weight, Body) 01/2021 - 01/2018
2	Ischemia 01/2021 - 01/2018
2	Ocular Hypertension (Glaucoma, Suspect) 02/2019 - 01/2017
2	Immune System Diseases (Immune Disorders) 01/2019 - 01/2016
2	Metabolic Diseases (Metabolic Disease) 01/2019 - 01/2018
2	Airway Remodeling 01/2019 - 01/2016
1	Pain (Aches) 10/2021
1	Hypersensitivity (Allergy) 01/2021
1	Arthritis (Polyarthritis) 10/2020
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2020
1	Overweight 01/2019
1	Obesity 01/2019
1	Chronic Disease (Chronic Diseases) 01/2019
1	Transient Ischemic Attack 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Brain Ischemia (Cerebral Ischemia) 01/2018
1	Neuroinflammatory Diseases 01/2017
1	Necrosis 01/2017
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2017
1	Hyperplasia 01/2016

Drug/Important Bio-Agent (IBA)

5	Histamine H4 ReceptorsIBA 11/2023 - 01/2016
4	Bleomycin (Blenoxane)FDA LinkGeneric 10/2020 - 01/2016
3	Interleukin-10 (Interleukin 10)IBA 10/2021 - 01/2019
3	Histamine (Histamine Dihydrochloride)FDA Link 02/2019 - 01/2016
3	LigandsIBA 01/2019 - 01/2016
2	Purinergic P1 Receptors (Adenosine Receptor)IBA 10/2021 - 01/2021
2	S-(2-guanidylethyl)isothioureaIBA 10/2021 - 01/2017
2	LipidsIBA 01/2021 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2018
2	FructoseIBA 01/2021 - 01/2018
2	1- ((5- chloro- 1H- indol- 2- yl)carbonyl)- 4- methylpiperazineIBA 01/2019 - 01/2018
2	Peroxidase (Myeloperoxidase)IBA 01/2019 - 01/2016
2	CytokinesIBA 01/2018 - 01/2016
2	CollagenIBA 01/2017 - 01/2016
1	GlucocorticoidsIBA 11/2023
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 10/2021
1	Interleukin-6 (Interleukin 6)IBA 10/2021
1	Histamine Receptors (Histamine Receptor)IBA 10/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021
1	Adenosine (Adenocard)FDA LinkGeneric 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	Carbonic Anhydrase InhibitorsIBA 10/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2020
1	ciproxifanIBA 02/2019
1	6- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA 02/2019
1	carbomerIBA 02/2019
1	Olive OilIBA 01/2019
1	AdiponectinIBA 01/2019
1	tagatose (D-tagatose)IBA 01/2018
1	SugarsIBA 01/2018
1	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 01/2018
1	MonosaccharidesIBA 01/2018
1	Neuroprotective AgentsIBA 01/2018
1	Melatonin Receptors (Melatonin Receptor)IBA 01/2018
1	1,2,5-oxadiazole 2-oxideIBA 01/2017
1	InterleukinsIBA 01/2017
1	8-Hydroxy-2'-DeoxyguanosineIBA 01/2016
1	Malondialdehyde (Propanedial)IBA 01/2016
1	Thiobarbituric Acid Reactive SubstancesIBA 01/2016
1	indium-bleomycinIBA 01/2016
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2016
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 01/2016

Therapy/Procedure

2	Therapeutics 02/2019 - 01/2019
1	Investigational Therapies (Experimental Therapy) 11/2023
1	Intravenous Administration 10/2021
1	Mediterranean Diet 01/2019